Jefferies Downgrades Ampio Pharmaceuticals To Hold

Analysts at Jefferies downgraded Ampio Pharmaceuticals AMPE from Buy to Hold. The target price for Ampio Pharmaceuticals has been lowered from $14 to $5. Ampio Pharmaceuticals shares have fallen 15.02% over the past 52 weeks, while the S&P 500 index has surged 19.77% in the same period. Ampio Pharmaceuticals' shares rose 0.71% to $5.70 in pre-market trading.